| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $136.9M | +7.6% | +25.5% |
| Cost of Revenue | $30.9M | +2.3% | +13.2% |
| Gross Profit | $106.0M | +9.3% | +29.6% |
| R&D Expense | $51.2M | +7.9% | +19.0% |
| SG&A Expense | $20.5M | +1.6% | +15.4% |
| Operating Income | -$21.6M | +16.9% | +27.8% |
| Pre-tax Income | -$14.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $78.4M | +52.8% | +25.9% |
| Short-term Investments | $572.7M | +2.2% | +41.2% |
| Accounts Receivable | $104.4M | +25.8% | +12.4% |
| Current Assets | $800.2M | +8.5% | +34.9% |
| Total Assets | $1.27B | +4.7% | +17.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $95.0M | — | — |
| Capital Expenditures | $2.6M | — | — |
| Investing Cash Flow | -$96.8M | — | — |
| Financing Cash Flow | $29.2M | — | — |
| Free Cash Flow | $92.4M | — | — |
| +24.2% |
| +38.4% |
| Income Tax | $1.5M | -24.4% | +219.5% |
| Net Income | -$16.4M | +24.2% | +28.4% |
| EPS (Basic) | -$0.14 | +26.3% | +33.3% |
| EPS (Diluted) | -$0.14 | +26.3% | +33.3% |
| $367.6M |
| +6.0% |
| +25.8% |
| Total Liabilities | $406.1M | +6.4% | +25.1% |
| Stockholders' Equity | $859.4M | +4.0% | +13.6% |